Drug Resistance Outpaces Global Health Action
Despite growing government commitments to tackle antimicrobial resistance (AMR), millions of patients remain vulnerable to infections that are increasingly difficult to treat because of inadequate laboratory testing, limited access to appropriate medicines and poorly implemented national strategies. A new World Health Organization (WHO) assessment reveals that although the number of countries with national AMR action…

